Both GMCR and CRM announce their respective earnings on Wednesday AMC (after market close) and both look to be 1.00 plus credit ($100/contract) earnings plays, so keep an eye on them through Wednesday's NY session and look to put on plays before Wednesday close if that's what you're going to do ... .
I have repeatedly gone at WMT and LOW to see whether I can squeeze enough out of those to make an earnings play worthwhile, but have been repeatedly disappointed to see that in spite of WMT's high IVR (99) and LOW's 75, that I have not been able to squeeze a 1.00 credit out of the standard 1 SD short strangle setup.
I'll have a look at them one more time closer to earnings to see whether something has changed there; otherwise, I'll look to deploy my buying power elsewhere or keep my powder dry for something more productive.
It spite of the fact that we've churned through most of the high profile earnings plays, some still remain that may be worth taking advantage of going forward. DE, MDT, COST, ADBE, NKE are high on my list, with NKE basically appearing at the end of this particular season in mid-December.
I have repeatedly gone at WMT and LOW to see whether I can squeeze enough out of those to make an earnings play worthwhile, but have been repeatedly disappointed to see that in spite of WMT's high IVR (99) and LOW's 75, that I have not been able to squeeze a 1.00 credit out of the standard 1 SD short strangle setup.
I'll have a look at them one more time closer to earnings to see whether something has changed there; otherwise, I'll look to deploy my buying power elsewhere or keep my powder dry for something more productive.
It spite of the fact that we've churned through most of the high profile earnings plays, some still remain that may be worth taking advantage of going forward. DE, MDT, COST, ADBE, NKE are high on my list, with NKE basically appearing at the end of this particular season in mid-December.